Form 4: Assembly Biosciences Executive Sells Shares to Cover Tax Obligations After RSU Vesting

Nicole S. White, Chief Manufacturing Officer of Assembly Biosciences, sold 1,255 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On April 29, 2024, Nicole S. White, Chief Manufacturing Officer of Assembly Biosciences, had a performance-based vesting condition achieved, resulting in 3,333 shares of common stock being issued under a restricted stock unit award from August 1, 2022.
• On April 30, 2024, White sold 1,255 shares of common stock at a weighted average price of $12.7068 per share, with prices ranging from $12.3851 to $12.8847.
• The sale was mandated by an administrative rule to cover tax withholding obligations related to the vesting of restricted stock units and does not represent a discretionary transaction.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, as it primarily reflects routine compensation and tax-related activities.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates activity related to equity compensation and tax obligations, which is common among publicly traded companies.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to be significant given the context of tax obligations.

Key Dates